CLASS II Device recall · Reported 30 Mar 2022 · FDA Enforcement Report

Codman Cranial Access Kits- indicated when a craniotomy is recalled

Integra LifeSciences is recalling Codman Cranial Access Kits- indicated when a craniotomy is required for placement of an, distributed nationwide in the US. The recall was initiated on 21 Jan 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Numbers: 20LDC222, 21HDC461 UDI# 10381780520375
Quantity recalled1161 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0817-2022
FDA event ID
89618
Recalling firm
Integra LifeSciences, Princeton, NJ
Classification
Class II
Status
Terminated
Recall initiated
21 Jan 2022
FDA classified
22 Mar 2022
Reported
30 Mar 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Device type
Spinal Implants

Timeline

21 Jan 2022Recall initiated by company
22 Mar 2022Classified by FDA+60 days
30 Mar 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Incorrect extended expiration dates identified on the outer box label only, if product is used past the correct expiration date there is a potential for pain, infection, or adverse tissue reaction to occur

Product as listed by the FDA

Codman Cranial Access Kits- indicated when a craniotomy is required for placement of an intracranial pressure (ICP) monitoring device and/or cerebrospinal fluid drainage procedures. Product umber: 826614

Where it was distributed

Worldwide distribution - US Nationwide and the country of Hong Kong.

Nationwide

Questions about this recall

Is Codman Cranial Access Kits- indicated when a craniotomy is required for placement of an recalled?

Yes. Integra LifeSciences recalled Codman Cranial Access Kits- indicated when a craniotomy is required for placement of an on 21 Jan 2022. The recall is Class II and its status is Terminated. Recall number Z-0817-2022.

Why was it recalled?

Incorrect extended expiration dates identified on the outer box label only, if product is used past the correct expiration date there is a potential for pain, infection, or adverse tissue reaction to occur

Which lots are affected?

Lot Numbers: 20LDC222, 21HDC461 UDI# 10381780520375

Where was it sold?

Worldwide distribution - US Nationwide and the country of Hong Kong.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Integra LifeSciences

All 246

Other Spinal Implants recalls

All 1,157